{"id":"https://openalex.org/W7225200930","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","title":"1079 Development of a biologically aligned ex vivo TumorGraft3D platform to evaluate STC-1010-mediated immune priming and colorectal tumor killing","display_name":"1079 Development of a biologically aligned ex vivo TumorGraft3D platform to evaluate STC-1010-mediated immune priming and colorectal tumor killing","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225200930","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1079"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1079","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1234.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1234.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029243551","display_name":"Ignacio Melero","orcid":"https://orcid.org/0000-0002-1360-348X","observed_orcids":["https://orcid.org/0000-0002-1360-348X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES","GB"],"is_corresponding":false,"raw_author_name":"Ignacio Melero","raw_affiliation_strings":["Clinica Universidad de Navarra and Cima and University of Oxford, Pamplona, Navarra, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Universidad de Navarra and Cima and University of Oxford, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160545293","display_name":"Margaux Frot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaux Frot","raw_affiliation_strings":["Brenus Pharma, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brenus Pharma, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009443091","display_name":"Fu-Ju Chou","orcid":"https://orcid.org/0000-0002-0727-5416","observed_orcids":["https://orcid.org/0000-0002-0727-5416"]},"institutions":[{"id":"https://openalex.org/I4210136821","display_name":"Champions Oncology (United States)","ror":"https://ror.org/04gbdgm24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fu-Ju Chou","raw_affiliation_strings":["Champions Oncology, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Champions Oncology, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210136821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086924526","display_name":"Sumanun Suwunnakorn","orcid":"https://orcid.org/0000-0002-1212-2182","observed_orcids":["https://orcid.org/0000-0002-1212-2182"]},"institutions":[{"id":"https://openalex.org/I4210136821","display_name":"Champions Oncology (United States)","ror":"https://ror.org/04gbdgm24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sumanun Suwunnakorn","raw_affiliation_strings":["Champions Oncology, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Champions Oncology, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210136821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001433701","display_name":"Marie Vallier","orcid":"https://orcid.org/0000-0002-7188-7070","observed_orcids":["https://orcid.org/0000-0002-7188-7070"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie Vallier","raw_affiliation_strings":["Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093712637","display_name":"Yannicke Pijoff","orcid":"https://orcid.org/0009-0001-0954-8991","observed_orcids":["https://orcid.org/0009-0001-0954-8991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yannicke Pijoff","raw_affiliation_strings":["Brenus Pharma, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brenus Pharma, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057490997","display_name":"Veena Jagannathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136821","display_name":"Champions Oncology (United States)","ror":"https://ror.org/04gbdgm24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Veena Jagannathan","raw_affiliation_strings":["Champions Oncology, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Champions Oncology, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I4210136821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101996583","display_name":"Maria Mancini","orcid":"https://orcid.org/0000-0001-9379-7335","observed_orcids":["https://orcid.org/0000-0001-9379-7335"]},"institutions":[{"id":"https://openalex.org/I4210136821","display_name":"Champions Oncology (United States)","ror":"https://ror.org/04gbdgm24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Mancini","raw_affiliation_strings":["Champions Oncology, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Champions Oncology, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210136821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068170896","display_name":"Benoit Pinteur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benoit Pinteur","raw_affiliation_strings":["Brenus Pharma, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brenus Pharma, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068069210","display_name":"George Alzeeb","orcid":"https://orcid.org/0000-0003-3492-823X","observed_orcids":["https://orcid.org/0000-0003-3492-823X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Alzeeb","raw_affiliation_strings":["Brenus-Pharma, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brenus-Pharma, Lyon, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043463827","display_name":"Fran\u00e7ois Ghiringhelli","orcid":"https://orcid.org/0000-0002-5465-8305","observed_orcids":["https://orcid.org/0000-0002-5465-8305"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Francois Ghiringhelli","raw_affiliation_strings":["Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1234","last_page":"A1234"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/active-immunotherapy","display_name":"active immunotherapy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.7630000114440918},{"id":"https://openalex.org/keywords/microsatellite-stable-colorectal-cancer","display_name":"microsatellite stable colorectal cancer","score":0.7699999809265137},{"id":"https://openalex.org/keywords/dendritic-cell-antigen-presentation","display_name":"dendritic cell antigen presentation","score":0.843999981880188},{"id":"https://openalex.org/keywords/cd8-t-cell-activation","display_name":"CD8+ T cell activation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.6420000195503235},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.7979999780654907},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hla-a2","display_name":"HLA-A2","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hct116-cells","display_name":"HCT116 cells","score":0.6470000147819519}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8363000154495239},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6693999767303467},{"id":"https://openalex.org/C81444415","wikidata":"https://www.wikidata.org/wiki/Q7243535","display_name":"Priming (agriculture)","level":3,"score":0.6176999807357788},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5863999724388123},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5045999884605408},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38580000400543213},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3190000057220459},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.29280000925064087},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.27379998564720154},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.26989999413490295},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.26440000534057617},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2630000114440918}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.1079","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1234.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1079","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1079","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1234.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225200930.pdf","grobid_xml":"https://content.openalex.org/works/W7225200930.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225142084","https://openalex.org/W7225174567","https://openalex.org/W2466762939","https://openalex.org/W7225190077","https://openalex.org/W7225143422","https://openalex.org/W4399880510","https://openalex.org/W4388048010","https://openalex.org/W7225144778","https://openalex.org/W2278754767","https://openalex.org/W7154724649"],"abstract_inverted_index":{"Background":[0],"Microsatellite-stable":[1],"metastatic":[2],"colorectal":[3,42],"cancer":[4,43],"(MSS":[5],"mCRC)":[6],"remains":[7,109],"poorly":[8],"responsive":[9],"to":[10,125,208,280,364,389],"immune":[11,264],"checkpoint":[12],"blockade,":[13],"supporting":[14,235,337,383],"immunotherapies":[15,392],"that":[16],"broaden":[17],"tumor":[18,93,215,269,276,478,509,518,525,537],"antigen":[19,62],"recognition.":[20],"STC-1010":[21,56,126,210,307,375],"is":[22,175],"an":[23],"allogeneic":[24],"multi-antigen":[25],"active":[26,106,391],"immunotherapy":[27,107],"generated":[28,475],"from":[29,85,116,278,358,400,412,429,444,446,468,476],"the":[30,54,306,340,384,422,563],"Stimulated":[31],"Ghost":[32],"Cell":[33],"platform":[34],"and":[35,40,67,129,144,161,169,197,204,214,226,232,273,313,333,367,418,426,436,466,514,520,531],"composed":[36],"of":[37,58,223,228,316,339,386,523,533,553],"stressed,":[38],"haptenated":[39,224],"inactivated":[41],"cell":[44],"lines.":[45],"We":[46,396],"designed":[47],"a":[48,75,187,350],"human":[49,490],"ex":[50,99,423],"vivo":[51,100,424],"workflow":[52,71,174,342],"reflecting":[53],"proposed":[55],"mechanism":[57],"action,":[59],"linking":[60],"dendritic-cell":[61],"capture/presentation,":[63],"CD8+":[64,133,547],"T-cell":[65,212],"activation":[66,137,213],"tumor-cell":[68,247],"killing.":[69],"This":[70,372],"was":[72,138,150,206,295],"advanced":[73],"toward":[74],"patient-aligned":[76],"translational":[77,352],"assay":[78,353],"using":[79,166,325],"clinically":[80,179,288,368,379,470],"annotated":[81,180,289,471],"TumorGraft3D":[82,182,192,293,370,387,459],"models":[83,388,460,474],"derived":[84,467],"well-characterized":[86],"PDX":[87],"models.":[88,183],"While":[89],"multiclonal":[90],"3D":[91,164,261,365,512],"organ-like":[92],"cultures":[94,155],"are":[95],"increasingly":[96],"used":[97],"for":[98,297,343,355,403,415,433,502],"drug":[101],"testing,":[102],"their":[103],"application":[104],"in":[105,152,162,178,249,393,511,544],"workflows":[108],"largely":[110],"unexplored.Methods":[111],"Monocyte-derived":[112],"dendritic":[113],"cells":[114,243,265,277,519,535],"(DCs)":[115],"HLA-A2":[117,447],"+":[118,241,448],"healthy":[119,449],"donor":[120,456,477],"PBMCs":[121,327,441],"were":[122,442,461,495],"matured,":[123],"exposed":[124],"or":[127,492,497],"vehicle,":[128],"co-cultured":[130],"with":[131,305,319,378,406,455,481,546],"autologous":[132],"T":[134,242,548],"cells.":[135,526],"DC":[136,332,335],"assessed":[139],"by":[140,156,195,252,271,463,499],"phenotyping,":[141],"cytokine":[142],"secretion":[143],"RNA-seq":[145],"pathway":[146],"analysis.":[147],"Tumor":[148,541],"killing":[149,321,362,510,538],"evaluated":[151],"HCT116":[153,163,246,260,540],"2D":[154,250,361],"live-cell":[157],"caspase-3/7":[158],"apoptosis":[159,248],"imaging":[160],"spheroids":[165,366],"GFP":[167,559],"viability":[168],"DRAQ7":[170,527],"dead-cell":[171],"readouts.":[172,322],"The":[173],"being":[176],"implemented":[177],"patient-derived":[181,472],"To":[184],"this":[185,503],"end,":[186],"confirmed":[188,296,328],"MSS,":[189,290],"HLA-A2-positive":[190,291],"CRC":[191,292],"model,":[193],"characterized":[194],"WES/RNA-seq":[196,300],"carrying":[198],"key":[199],"mutations":[200],"(KRAS,":[201],"APC,":[202],"TP53":[203],"PIK3CA)":[205],"selected":[207],"evaluate":[209,390],"induced":[211],"killing.Results":[216],"STC-1010-treated":[217],"mature":[218,334],"DCs":[219],"showed":[220],"selective":[221],"detection":[222],"material":[225],"enrichment":[227],"antigen-processing/presentation,":[229],"phagosome,":[230],"lysosome":[231],"cytokine\u2013receptor":[233],"pathways,":[234],"APC":[236],"activation.":[237],"Functionally,":[238],"STC-1010-primed":[239,263],"CD8":[240],"significantly":[244,266,515],"increased":[245,274],"culture":[251],"1.9-fold":[253],"versus":[254],"vehicle":[255],"(P":[256],"=":[257],"0.0003).":[258],"In":[259],"spheroids,":[262],"reduced":[267],"viable":[268,517],"signal":[270],"55\u201360%":[272],"dead":[275,524,534],"35\u201340%":[279],"50\u201355%":[281],"at":[282,549],"Day":[283],"7":[284],"(figure":[285],"1).":[286],"A":[287],"model":[294,513],"implementation.":[298],"Its":[299],"data,":[301],"enabling":[302],"molecular":[303],"alignment":[304],"first-in-human":[308],"clinical":[309],"trial":[310],"(NCT06934538)":[311],"population":[312],"future":[314],"integration":[315],"tumor-intrinsic":[317],"features":[318],"immune-mediated":[320],"Feasibility":[323],"experiments":[324],"cryopreserved":[326],"distinct":[329],"monocyte,":[330],"immature":[331],"phenotypes,":[336],"compatibility":[338],"T-cell-priming":[341],"downstream":[344],"TumorGraft3D-based":[345],"applications.Conclusions":[346],"These":[347],"data":[348],"support":[349,405,435],"stepwise":[351],"strategy":[354],"STC-1010,":[356],"progressing":[357],"mechanistically":[359],"informed":[360,457,482],"assays":[363],"aligned":[369],"testing.":[371],"approach":[373],"links":[374],"mechanism-of-action":[376],"readouts":[377],"relevant":[380],"tumor-killing":[381],"endpoints,":[382],"use":[385],"MSS":[394],"mCRC.Acknowledgements":[395],"thank":[397],"Claudia":[398],"Carenza":[399],"Champions":[401,413,464],"Oncology":[402,414,465],"her":[404,416],"flow":[407],"cytometry":[408],"analysis,":[409],"BanuPriya":[410],"Sridharan":[411],"scientific":[417,437],"operational":[419],"guidance":[420],"on":[421],"work,":[425],"Romain":[427],"Boidot":[428],"Centre":[430],"Georges-Fran\u00e7ois":[431],"Leclerc":[432],"his":[434],"input.Ethics":[438],"Approval":[439],"Human":[440],"obtained":[443],"BioIVT":[445],"donors":[450],"under":[451,484],"IRB-approved":[452],"collection":[453],"protocols":[454],"consent.":[458],"provided":[462],"de-identified,":[469],"TumorGraft/PDX":[473],"specimens":[479],"collected":[480],"consent":[483],"applicable":[485],"IRB/ethical":[486],"approvals.":[487],"No":[488],"new":[489],"participants":[491],"animal":[493],"procedures":[494],"enrolled":[496],"performed":[498],"Brenus":[500],"Pharma":[501],"study.Abstract":[504],"1079":[505],"Figure":[506],"1STC-1010":[507],"induces":[508],"reduces":[516],"increases":[521],"%":[522],"Imaging":[528],":":[529],"Identification":[530],"quantification":[532],"during":[536,562],"assay.":[539],"Microtissue":[542],"(TuMT)":[543],"co-culture":[545,564],"day":[550],"7:":[551],"end":[552],"co-culture)":[554],"(Scale":[555],"bar":[556],"100":[557],"\u00b5m).":[558],"Intensity":[560],"measurement":[561]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}